Difference between revisions of "SPECT Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
Line 2: Line 2:
 
:Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD  
 
:Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD  
 
:Secretary: Julie Lisiecki
 
:Secretary: Julie Lisiecki
−
:[[Media:QIBA SPECT Roster.pdf|'''Roster''']]
+
* [http://tinyurl.com/QIBA-SPECT-Roster Roster]
  
 
==Project Snapshot==
 
==Project Snapshot==

Revision as of 19:28, 23 October 2017

Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD
Secretary: Julie Lisiecki

Project Snapshot

The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.

Under consideration:

  • quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
  • quantifying organs, like the liver, for dosimetry as potential use cases

Established Task Forces currently working toward a first Profile titled: Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease

  • Image Acquisition and Image Processing for DaTscan – Dr. Dewaraja
  • Quantitative / Image Analysis – Drs. Miyaoka and Seibyl
  • Phantoms / DRO Group – Drs. Dickson and Zimmerman
  • Clinical / Literature Review – Dr. Seibyl

Meetings/Call Summaries

Literature Review (Profile 1.0)

Profile Development

Reference Materials


Retrieved from "https://qibawiki.rsna.org/index.php?title=SPECT_Biomarker_Ctte&oldid=11803"